Switching α-Glucosidase Inhibitors to Miglitol Reduced Glucose Fluctuations and Circulating Cardiovascular Disease Risk Factors in Type 2 Diabetic Japanese Patients

BACKGROUND AND OBJECTIVES: In this study we examined the effects of switching α-glucosidase inhibitors (α-GI) from acarbose or voglibose to miglitol on glucose fluctuations and circulating concentrations of cardiovascular disease risk factors, such as soluble adhesion molecules (sE-selectin, sICAM-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Hariya, Natsuyo, Mochizuki, Kazuki, Inoue, Seiya, Saito, Miyoko, Fuchigami, Masahiro, Goda, Toshinao, Osonoi, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153962/
https://www.ncbi.nlm.nih.gov/pubmed/25079671
http://dx.doi.org/10.1007/s40268-014-0055-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153962/
https://www.ncbi.nlm.nih.gov/pubmed/25079671
http://dx.doi.org/10.1007/s40268-014-0055-7

Ejemplares similares